PNW
55
3
ADI
54
4
MTCH
62
22
GRMN
53
3
MSFT
55
2
RL
73
5
PNR
56
2
LB
16
9
HPQ
55
3
KHC
11
2
GM
55
6
OI
23
3
EFX
43
3
CI
35
2
AA
27
5
VIX
41
-11
HBI
53
4
PPL
44
9
PFE
37
4
ADBE
50
3
PNW
55
3
ADI
54
4
MTCH
62
22
GRMN
53
3
MSFT
55
2
RL
73
5
PNR
56
2
LB
16
9
HPQ
55
3
KHC
11
2
GM
55
6
OI
23
3
EFX
43
3
CI
35
2
AA
27
5
VIX
41
-11
HBI
53
4
PPL
44
9
PFE
37
4
ADBE
50
3
Financhill
Back

Regencell Bioscience Holdings 10K Form

Sell
25

RGC
Regencell Bioscience Holdings

Last Price:
$4.90
Seasonality Move:
-17.94%

7 Day Trial

ALL ACCESS PASS

$ 7

Key Filings

10K form not available

Receive RGC News And Ratings

See the #1 stock for the next 7 days that we like better than RGC

RGC Financial Statistics

Sales & Book Value

Annual Sales: $3.2B
Cash Flow: $0
Price / Cash Flow: 0
Annual Sales: $0.63
Price / Book: 7.79

Profitability

EPS (TTM): -0.33000
Net Income (TTM): $-4.3M
Gross Margin: $2B
Return on Equity: 0%
Return on Assets: 0%

Regencell Bioscience Holdings Earnings Forecast

Key Regencell Bioscience Holdings Financial Ratios

  • The Gross Profit Margin over the past 13 years for RGC is 62.33%.
  • The Selling, General & Administrative Expenses for RGC have been equal to 16.23% of Gross Profit Margin.
  • The Interest Expense is 0.00% of Operating Income.
  • Per Share Earnings over the last 19 years have been positive in 8 years.

Regencell Bioscience Holdings Stock Price Chart

Industry, Sector and Symbol

Stock Exchange: NASDAQ
Industry: Pharmaceuticals
Sector: Health Care
Current Symbol: RGC
Website: regencellbioscience.com

Debt

Debt-to-Equity Ratio: 0
Current Ratio: 0
Quick Ratio: 0

Price-to-Earnings

Trailing P/E Ratio: 0
Forward P/E Ratio: 0

RGC Technical Analysis vs Fundamental Analysis

Sell
25
Regencell Bioscience Holdings (RGC) is a Sell

Is Regencell Bioscience Holdings a Buy or a Sell?